JAFRAL contributes to a groundbreaking gene therapy clinical trial We are proud to announce that JAFRAL has been GMP manufacturer in Europe’s first clinical trial of [...]
9th AMR Conference 2025, Switzerland, 2025 Our CEO, dr.Frenk Smrekar, will be present at AMR conference in Basel. He is happy to discuss how phage therapy [...]
JAFRAL as part of PhageEU coalition in EU Parliament, Brussels, 2024 We are pleased that JAFRAL was be part of PhageEU coalition in EU Parliament, where [...]
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok